Scientists create world’s first mini-brain with working blood-brain barrier
UC, Cincinnati Children's researcher featured in Interesting Engineering
Interesting Engineering recently highlighted research led by University of Cincinnati and Cincinnati Children's Hospital researcher Ziyuan Guo that developed the first human mini-brain that incorporates a fully functional blood-brain barrier (BBB).
In collaboration with researchers at the Mayo Clinic and University of California San Diego, the researchers said this breakthrough could help accelerate the understanding of and development of novel treatments for many brain disorders including cancer, Alzheimer's disease and Parkinson's disease.
“Lack of an authentic human BBB model has been a major hurdle in studying neurological diseases," said lead author Ziyuan Guo, PhD, assistant professor in the Department of Pediatrics in UC's College of Medicine and researcher at Cincinnati Children's. "Our breakthrough involves the generation of human BBB organoids from human pluripotent stem cells, mimicking human neurovascular development to produce a faithful representation of the barrier in growing, functioning brain tissue. This is an important advance because animal models we currently use in research do not accurately reflect human brain development and BBB functionality.
"“Now, through stem cell bioengineering, we have developed an innovative platform based on human stem cells that allows us to study the intricate mechanisms governing BBB function and dysfunction," Guo continued. "This provides unprecedented opportunities for drug discovery and therapeutic intervention."
Read the Interesting Engineering article.
The research was also featured in Drug Target Review. Read the Drug Target Review article.
Featured photo at top of neurons. photo/Imaginima/iStock.
Related Stories
UC experts present neurology research at national conference
April 17, 2026
University of Cincinnati researchers will present abstracts at the 2026 American Academy of Neurology Annual Meeting April 18 to 22 in Chicago.
AI advances in the liver disease field
April 15, 2026
MASH represents the advanced inflammatory form of metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as nonalcoholic fatty liver disease), where fat accumulation in the liver triggers fibrosis and progressive liver injury. According to a recent MedCentral article, more AI-based clinical assessment tools in MASH are needed.
UC Graduate College honors 2026 Graduate Student Research Award recipients during Research + Innovation Week
April 15, 2026
The University of Cincinnati Graduate College is proud to announce the recipients of the 2026 Graduate Student Research Awards, recognizing doctoral students whose research, scholarship, and creative work demonstrate excellence in innovation, impact and interdisciplinarity.